Wang Shan, Zhang Feng-Ying, Dou Xue, Pan Xiao-Lin, Su Chen, Tian Jin-Lei, Mu Dian-Ping
Department of Pharmacy, Tianjin First Central Hospital, Nankai University, Tianjin, China.
College of Chemistry, Nankai University, Tianjin, China.
Oncol Rev. 2025 Jan 6;18:1415677. doi: 10.3389/or.2024.1415677. eCollection 2024.
The administered infusion solution is a sterile preparation that can be used directly for intravenous infusion in patients by mixing one or more intravenous drugs using aseptic operation technology. The pharmacy intravenous admixture service (PIVAS) center is a professional technical service department in hospitals, where the majority of inpatient-administered infusion solutions are prepared. During the processes of dissolution, dilution, preparation, storage, and use of intravenous drugs, the quality control of the administered infusion solution can be affected by various factors. At present, there are no relevant standards or guidance documents for the quality control of administered infusion solutions. Cytotoxic drugs are still the main treatment option for cancer patients and are mainly prepared in PIVAS centers in most hospitals. In this study, we mainly focused on the quality control of cytotoxic drug-administered infusion solutions and explored associated factors (diluent, container, concentration, temperature, and light), physical stability (visual appearance, pH, osmolality, and particulate matter), chemical stability (content), and biological stability (sterility). Most of the studies reviewed in this paper have insufficient data on the related factors and physicochemical stability of the administered infusion solutions. Research on the sterility of administered infusion solutions is particularly limited, with only one article addressing this aspect. Ensuring the quality of cytotoxic drug-administered infusion solutions is vital for the safe administration of drugs to cancer patients, so it is very important to enhance associated research. This article summarized the relevant literature on the quality control of cytotoxic drug-administered infusion solutions and provided a reference for safer and more efficient use of these drugs in clinical practice.
所输注的输液制剂是一种无菌制剂,通过无菌操作技术混合一种或多种静脉用药物后可直接用于患者静脉输注。医院药房静脉药物配置中心(PIVAS)是医院的一个专业技术服务部门,大多数住院患者使用的输液制剂在此配制。在静脉用药物的溶解、稀释、配制、储存及使用过程中,所输注输液制剂的质量控制会受到多种因素影响。目前,对于所输注输液制剂的质量控制尚无相关标准或指导文件。细胞毒性药物仍是癌症患者的主要治疗选择,多数医院主要在PIVAS中心配制。本研究主要聚焦于细胞毒性药物输注液的质量控制,并探讨相关因素(稀释剂、容器、浓度、温度和光照)、物理稳定性(外观、pH值、渗透压和微粒)、化学稳定性(含量)及生物稳定性(无菌性)。本文综述的大多数研究关于所输注输液制剂的相关因素及理化稳定性的数据不足。关于所输注输液制剂无菌性的研究尤其有限,仅有一篇文章涉及这方面内容。确保细胞毒性药物输注液的质量对于癌症患者安全用药至关重要,因此加强相关研究非常重要。本文总结了细胞毒性药物输注液质量控制的相关文献,为临床更安全、高效地使用这些药物提供参考。